| 1. |
Oshima H, Katayama Y. Discovery of cerebrovascular moyamoya disease: research during the late 1950s and early 1960s[J]. Childs Nerv Syst, 2012, 28(4): 497-500. DOI: 10.1007/s00381-012-1708-x.
|
| 2. |
Bakri SJ, Siker D, Masaryk T, et al. Ocular malformations, moyamoya disease, and midline cranial defects: a distinct syndrome[J]. Am J Ophthalmol, 1999, 127(3): 356-357. DOI: 10.1016/s0002-9394(98)00317-1.
|
| 3. |
Khan N, Schinzel A, Shuknecht B, et al. Moyamoya angiopathy with dolichoectatic internal carotid arteries patent ductus arteriosus and pupillary dysfunction: a new genetic syndrome?[J]. Eur Neurol, 2004, 51(2): 72-77. DOI: 10.1159/000076248.
|
| 4. |
Kumar MA, Ganesh BA. CRAO in moyamoya disease[J]. J Clin Diagn Res, 2013, 7(3): 545-547. DOI: 10.7860/JCDR/2013/4579.2819.
|
| 5. |
Ebert JJ, Sisk RA. CRAO in moyamoya syndrome associated with Southampton hemoglobinopathy[J/OL]. Ophthalmic Surg Laser Imag Retina, 2019, 50(5): e166-e170[2019-05-01]. https://pubmed.ncbi.nlm.nih.gov/31100171/. DOI: 10.3928/23258160-20190503-17.
|
| 6. |
Hayreh SS. Central retinal artery occlusion[J]. Indian J Ophthalmol, 2018, 66(12): 1684-1694. DOI: 10.4103/ijo.IJO_1446_18.
|
| 7. |
Ratra D, Dhupper M. Retinal artery occlusion in the young: systemic associations in Indian population[J]. Indian J Ophthalmol, 2012, 60(2): 95-100. DOI: 10.4103/0301-4738.94049.
|
| 8. |
Hirsch S, Pia De la Maza M, Yañez P, et al. Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation[J]. Clin Cardiol, 2002, 25(11): 495-501. DOI: 10.1002/clc.4960251105.
|
| 9. |
Cahill M, Karabatzaki M, Meleady R, et al. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease[J]. Br J Ophthalmol, 2000, 84(2): 154-157. DOI: 10.1136/bjo.84.2.154.
|
